Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Performance of E6/E7 mRNA to Detect Anal High-Grade Intraepithelial Lesions and Cost-effectiveness Analysis of a New Screening Strategy for Anal Cancer in HIV Positive Men Who Have Sex With Men

NCT03357991 is registered in ClinicalTrials.gov with Hospital Universitari de Bellvitge as lead sponsor.

NCT NCT03357991
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03357991 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Performance of E6/E7 mRNA to Detect Anal High-Grade Intraepithelial Lesions and Cost-effectiveness Analysis of a New Screening Strategy for Anal Cancer in HIV Positive Men Who Have Sex With Men
Lead sponsor
Hospital Universitari de Bellvitge
Phase
Observational
Overall status
Unknown status
Start date
January 11, 2015
Completion date
June 30, 2020
Enrollment
355 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anal cancer, hiv, hpv - anogenital human papilloma virus infection, hsil, high grade squamous intraepithelial lesions